Viewing Study NCT01197560


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-02-22 @ 2:13 AM
Study NCT ID: NCT01197560
Status: COMPLETED
Last Update Posted: 2019-11-25
First Post: 2010-07-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Sponsor: Celgene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diffuse Large B-Cell Lymphoma View
None Non Hodgkin's Lymphoma View
None relapsed View
None refractory View
None relapsed/refractory View
None DLBCL View
None Diffuse Large B Cell Lymphoma View